'Revolutionary' drug for prostate cancer October 1, 2019 Olaparib could become a revolutionary treatment for prostate cancer - the first genetically targeted drug for fighting the disease, say experts.The precision medicine is already used by the NHS for ovarian cancer and has been called a game-changer by cancer doctors.Read the full article here.Source: BBC Prostate Cancer News
Olaparib could become a revolutionary treatment for prostate cancer - the first genetically targeted drug for fighting the disease, say experts.The precision medicine is already used by the NHS for ovarian cancer and has been called a game-changer by cancer doctors.Read the full article here.Source: BBC
